Versant Ventures

Versant. Invested in Life.

  • Share
  • LP Access
  • Contact Us
  • Careers
  • About
    • Versant Overview
    • Vision
    • Contact Us
  • Team
    • Team Overview
    • Brian Atwood
    • Bradley Bolzon, PhD
    • Samuel Colella
    • Ross Jaffe, MD
    • William Link, PhD
    • Barbara Lubash
    • Donald Milder
    • Kirk Nielsen
    • Robin Praeger – CFO
    • Rebecca Robertson
    • Charles Warden
    • Bobak Azamian, MD, DPhil
    • Jerel Davis, PhD
    • Alicia Levey, PhD
    • Carlo Rizzuto, PhD
    • Mike Rosenbluth, PhD
    • Scott Chetham, Ph.D.
    • Gianni Gromo, MD, PhD
    • Stephen Kaldor, PhD
    • Guido Magni, MD, PhD
    • Thomas Woiwode, PhD
    • Camille Samuels
    • Kevin Wasserstein
  • Portfolio
    • Portfolio Overview
    • Biotechnology
    • Biotechnology Exits & IPOs
    • Medical Devices
    • Medical Device Exits & IPOs
    • Additional Investments
    • Additional Investment Exits
    • Incubator Relationships
    • Amira Pharmaceuticals
    • Quanticel Pharmaceuticals
  • Entrepreneurs
    • Entrepreneur Essentials
    • Submit A Business Plan
  • News & Events
    • In The News
    • Versant Events

Featured Case Study

Small molecules, targeted therapies.

Small molecules, targeted therapies.

BIOTECHNOLOGY

Amira Takes Targeted Path

Amira was founded in 2005 by a proven team of former Merck scientists. Responsible for the development of multiple billion-dollar products, these researchers were eager to discover and develop additional game-changing therapeutics. At the core of the Amira discovery and development engine was a distinctly forward-looking, commercial outlook. Decision-making at the earliest discovery...

Full Amira Case Study
All Case Studies

News Highlights

Second Sight Receives First Retinal Implant FDA Approval

Download PDF

Dr. Rizzuto Joins Versant as Operating Principal

Download PDF

Versant, Roche Launch New-model Biotech Startup

Download PDF

KYTHERA Announces IPO

Download PDF

All News Articles

  • Legal
  • Site Map
  • Home

© 2013 Versant Ventures, Inc. All Rights Reserved